Skip to main content

U.S. investors, Big Pharma race to find new medicines in China

U.S. investors and large pharmaceutical companies are increasingly doing deals in China as the country's biopharma sector transforms.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.